Black Diamond Therapeutics (BDTX) Ownership - Who Owns Black Diamond Therapeutics?

1,610 Followers

Black Diamond Therapeutics (BDTX) Ownership Overview

9.03% Insiders

16.29% Mutual Funds

34.13% Other Institutional Investors

7.31% ETFs

33.24% Public Companies and

Individual Investors

The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail, and individual investors. Approximately 57.72% of the company’s stock is owned by Institutional Investors, 9.03% is owned by Insiders, and 33.24% is owned by Public Companies and Individual Investors.

The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail, and individual investors. Approximately 50.42% of the company’s stock is owned by Institutional Investors, 9.03% is owned by Insiders, and 7.31% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Royce & Associates Llc	xxxxxxxxxxxxx	$35850
Dec 31, 2023	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$364015

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
4,542,325	Insider	7.93%	12,491,394
2,650,444	Institution	4.63%	7,288,721
2,132,966	Institution	3.72%	5,865,657
1,792,699	Institution	3.13%	4,929,922
1,762,333	Institution	3.08%	4,846,416
1,396,549	Institution	2.44%	3,840,510
750,192	Institution	1.31%	2,063,028
524,382	Institution	0.92%	1,442,051
496,001	Institution	0.87%	1,364,003
467,750	Institution	0.82%	1,286,313

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
2,650,444	Institution	4.63%	7,288,721
2,132,966	Institution	3.72%	5,865,657
1,762,333	Institution	3.08%	4,846,416
1,396,549	Institution	2.44%	3,840,510
467,750	Institution	0.82%	1,286,313
413,342	Institution	0.72%	1,136,691
163,000	Institution	0.28%	448,250
152,352	Institution	0.27%	418,968
53,625	Institution	0.09%	147,469
46,461	Institution	0.08%	127,768

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	1,297,051	Institution	2.26%	2,762,719
Vanguard Extended Market ETF	495,648	Institution	0.86%	1,055,730
Fidelity Enhanced Small Cap ETF	493,854	Institution	0.86%	1,451,931
iShares Biotechnology ETF	340,582	Institution	0.59%	963,847
EA Bridgeway Omni Small-Cap Value ETF	239,501	Institution	0.42%	704,133
iShares MSCI USA Small-Cap Multifactor ETF	218,559	Institution	0.38%	618,522
Dimensional U.S. Small Cap ETF	190,895	Institution	0.33%	561,231
Dimensional US Small Cap Value ETF	167,918	Institution	0.29%	493,679
iShares Micro-Cap ETF	117,727	Institution	0.21%	333,167
Invesco FTSE RAFI US 1500 Small-Mid ETF	103,743	Institution	0.18%	293,593

FAQ

Who Owns Black Diamond Therapeutics (BDTX)?

According to the latest TipRanks data, approximately 34.13% of the company's stock is held by institutional investors, 9.03% is held by insiders, and 33.24% is held by retail investors.

What percentage of Black Diamond Therapeutics (BDTX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 34.13% of Black Diamond Therapeutics (BDTX) stock is held by institutional investors.

What percentage of Black Diamond Therapeutics (BDTX) stock is held by retail investors?

According to the latest TipRanks data, approximately 33.24% of Black Diamond Therapeutics (BDTX) stock is held by retail investors.

Who owns the most shares of Black Diamond Therapeutics (BDTX)?

Ali Behbahani owns the most shares of Black Diamond Therapeutics (BDTX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.